Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

ClinicalTrials.gov ID: NCT00815607

Public ClinicalTrials.gov record NCT00815607. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 1b' Open Label, Single Arm, Multicenter Trial to Evaluate the Safety, Tolerance, Response Rate and Immunological Effects of Repeated Intratumoral Injections of Adenoviral Transduced Autologous Dendritic Cells Engineered to Express hIL-12(INXN-3001) in Response to an Oral Activator Ligand in Patients With Unresectable Stage III C or IV Malignant Melanoma

Study identification

NCT ID: NCT00815607
Recruitment status: Completed
Study type: Interventional
Phase: Phase 1
Lead sponsor: Alaunos Therapeutics; Industry
Enrollment: 12 participants

Conditions and interventions

Conditions

Melanoma

Interventions

INXN-1001 Drug
INXN-3001 Biological

Drug · Biological

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 31, 2009
Primary completion: Dec 31, 2012
Completion: Dec 31, 2012
Last update posted: Jul 17, 2013

2009 – 2013

United States locations

U.S. sites: 8
U.S. states: 8
U.S. cities: 8

Facility	City	State	ZIP	Site status
The Angeles Clinic and Research Institute	Santa Monica	California	90404	—
Helen F. Graham Cancer Center	Newark	Delaware	19713	—
• Nancy N. and J.C. Lewis Cancer Center & Research Pavilion at St. Joseph/Candles	Savannah	Georgia	31405	—
Oncology Specialists, S.C.	Park Ridge	Illinois	60068	—
Goshen Clinic	Goshen	Indiana	46526	—
Billings Clinic	Billings	Montana	59101	—
Penn State Milton S. Hershey Medical Center	Hershey	Pennsylvania	17033	—
Mary Crowley Cancer Research Centers	Dallas	Texas	75201	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00815607, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 17, 2013 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00815607 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →